Neuroscience
A new study has been funded to examine the use of olfactory testing in the earlier detection of Alzheimer's disease, one of my interests in neuropsychological assessment.
The study is being funded and run is Australia.
Here is a news report, from The Australian:
Research funding boost for Alzheimer's
SUE DUNLEVY
October 17, 2011 12:00AM
[snippet]
"We are interested in developing a test that picks up Alzheimer's disease in the earliest stages, even before problems with cognition appear," he told The Australian. Adapting the strategy of the cardiac stress test that picks up heart disease in its early stages, Professor Schofield wants to see whether a smell test can identify people who later go on to develop Alzheimer's.
Participants in the trial would be asked to scratch, sniff and identify 20 smells embedded in a piece of paper, then they would be given a chemical in their left nostril that interfered with the part of the olfactory system affected by Alzheimer's. Patients would be given a further 20 smells to identify after the chemical was administered. If it proved successful, the test would cost just $35 and be much cheaper than imaging techniques used now to identify people in the pre-clinical stages of Alzheimer's, Professor Schofield said.
[snippet]
Read the full story
- World Alzheimer's Day
Today is World Alzheimer's Day. Read something today to increase your knowledge about the disease and dementia. Here's a general-readership resource: Alzheimer's Disease: Unraveling the Mystery ... and a report from the Alzheimer's Association:...
- Dementia And The Sniff Magnitude Test
From today's New York Times: Sniff Test May Signal Disorders’ Early Stages By ELIZABETH SVOBODA Published: August 14, 2007 [snip] The Sniff Magnitude Test, developed with the aid of a $1.3 million grant from the National Institutes of Health, consists...
- Neuropsychology Abstract Of The Day: Olfactory Functioning And Mild Cognitive Impairment (mci)
Djordjevic J, Jones-Gotman M, De Sousa K, & Chertkow H. (2007). Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiology and Aging [epub ahead of print.] Montreal Neurological Institute, 3801 University Street, Department...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
- Imaging Alzheimer Disease - Part 2
Today's Yale Daily News includes an article about last week's announcement about the initiative to examine imaging technologies in the diagnosis of Alzheimer disease. The article is interesting to read of itself, but also because it touches briefly...
Neuroscience
Olfaction and Alzheimer's Disease
A new study has been funded to examine the use of olfactory testing in the earlier detection of Alzheimer's disease, one of my interests in neuropsychological assessment.
The study is being funded and run is Australia.
Here is a news report, from The Australian:
Research funding boost for Alzheimer's
SUE DUNLEVY
October 17, 2011 12:00AM
[snippet]
"We are interested in developing a test that picks up Alzheimer's disease in the earliest stages, even before problems with cognition appear," he told The Australian. Adapting the strategy of the cardiac stress test that picks up heart disease in its early stages, Professor Schofield wants to see whether a smell test can identify people who later go on to develop Alzheimer's.
Participants in the trial would be asked to scratch, sniff and identify 20 smells embedded in a piece of paper, then they would be given a chemical in their left nostril that interfered with the part of the olfactory system affected by Alzheimer's. Patients would be given a further 20 smells to identify after the chemical was administered. If it proved successful, the test would cost just $35 and be much cheaper than imaging techniques used now to identify people in the pre-clinical stages of Alzheimer's, Professor Schofield said.
[snippet]
Read the full story
- World Alzheimer's Day
Today is World Alzheimer's Day. Read something today to increase your knowledge about the disease and dementia. Here's a general-readership resource: Alzheimer's Disease: Unraveling the Mystery ... and a report from the Alzheimer's Association:...
- Dementia And The Sniff Magnitude Test
From today's New York Times: Sniff Test May Signal Disorders’ Early Stages By ELIZABETH SVOBODA Published: August 14, 2007 [snip] The Sniff Magnitude Test, developed with the aid of a $1.3 million grant from the National Institutes of Health, consists...
- Neuropsychology Abstract Of The Day: Olfactory Functioning And Mild Cognitive Impairment (mci)
Djordjevic J, Jones-Gotman M, De Sousa K, & Chertkow H. (2007). Olfaction in patients with mild cognitive impairment and Alzheimer's disease. Neurobiology and Aging [epub ahead of print.] Montreal Neurological Institute, 3801 University Street, Department...
- Business World: Myriad Genetics, Flurizan (mpc-7869), And Alzheimer Disease
From the AP, via Yahoo! News: Largest-Ever Alzheimer's Drug Trial Begins By PAUL ELIAS, AP Biotechnology Writer Sun Mar 12, 6:58 AM ET SAN FRANCISCO - It's tragedy enough that Pat Williams' mother...
- Imaging Alzheimer Disease - Part 2
Today's Yale Daily News includes an article about last week's announcement about the initiative to examine imaging technologies in the diagnosis of Alzheimer disease. The article is interesting to read of itself, but also because it touches briefly...